Related Experiment Video
Updated: Apr 23, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Practice Variation for Platelet Transfusion in Patients with Severe Refractory Thrombocytopenia: A Survey of Critical
Alina O Dulu1, Sanjay Chawla1,2, Neema Jayachamarajapura Onkaramurthy1
1Critical Care Center, Department of Anesthesiology & Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
BackgroundSevere thrombocytopenia refractory to platelet transfusion is an increasingly common issue and poses challenges for safely performing procedures in the intensive care unit (ICU).ObjectiveTo describe platelet transfusion thresholds and strategies ICU clinicians use when performing invasive procedures with general low bleeding risk in patients with severe refractory thrombocytopenia (below 5000/mm3), a scenario for which no current guideline recommendations exist.DesignCross-sectional web-based survey of ICU clinicians in adult oncologic ICUResultsOf 110 ICU clinicians 65 (59%) completed the survey (median IQR age: 36 years (31-43), 63% female). For placing a central venous catheter (CVC) majority (60%) chose a platelet transfusion threshold <20 000/mm3, while 40% chose a threshold ≥20 000/mm3. Lower thresholds were used frequently by Fellows, APPs, and clinicians with ≤5 years experience in ICU or < 50 CVC placements experience, whereas CCM attendings and more experienced clinicians favored higher thresholds (P = .015). Majority (74%) transfused one unit of platelets while performing the procedure under ultrasound guidance. The internal jugular vein was the preferred site (63%). Similar strategies and platelet thresholds were employed for hemodyalisis catheter (HD) placement. Desmopressin was administered by 55% before HD catheter placement. Thirty-seven percent reported patients with platelet counts below 20 000/mm3 undergoing line placement never required post-procedure transfusion for bleeding.ConclusionsThe survey shows that ICU clinicians are safely and comfortably performing procedures at platelet thresholds below 20,000, revealing a gap between guideline recommendations and real-world practice and a need for additional evidence to guide invasive procedures in this population.
BackgroundSevere thrombocytopenia refractory to platelet transfusion is an increasingly common issue and poses challenges for safely performing procedures in the intensive care unit (ICU).ObjectiveTo describe platelet transfusion thresholds and strategies ICU clinicians use when performing invasive procedures with general low bleeding risk in patients with severe refractory thrombocytopenia (below 5000/mm3), a scenario for which no current guideline recommendations exist.DesignCross-sectional web-based survey of ICU clinicians in adult oncologic ICUResultsOf 110 ICU clinicians 65 (59%) completed the survey (median IQR age: 36 years (31-43), 63% female). For placing a central venous catheter (CVC) majority (60%) chose a platelet transfusion threshold <20 000/mm3, while 40% chose a threshold ≥20 000/mm3. Lower thresholds were used frequently by Fellows, APPs, and clinicians with ≤5 years experience in ICU or < 50 CVC placements experience, whereas CCM attendings and more experienced clinicians favored higher thresholds (P = .015). Majority (74%) transfused one unit of platelets while performing the procedure under ultrasound guidance. The internal jugular vein was the preferred site (63%). Similar strategies and platelet thresholds were employed for hemodyalisis catheter (HD) placement. Desmopressin was administered by 55% before HD catheter placement. Thirty-seven percent reported patients with platelet counts below 20 000/mm3 undergoing line placement never required post-procedure transfusion for bleeding.ConclusionsThe survey shows that ICU clinicians are safely and comfortably performing procedures at platelet thresholds below 20,000, revealing a gap between guideline recommendations and real-world practice and a need for additional evidence to guide invasive procedures in this population.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Venous Thrombosis III: Interprofessional Care
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

